253 related articles for article (PubMed ID: 34483932)
1. USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1.
Li G; Yang T; Chen Y; Bao J; Wu D; Hu X; Feng C; Xu L; Li M; Li G; Jin M; Xu Y; Zhang R; Qian G; Pan J
Front Pharmacol; 2021; 12():720307. PubMed ID: 34483932
[TBL] [Abstract][Full Text] [Related]
2. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.
Li XY; Wu HY; Mao XF; Jiang LX; Wang YX
Biochem Biophys Res Commun; 2017 Oct; 492(1):48-54. PubMed ID: 28807830
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.
Zhang Z; Cui Z; Xie Z; Li C; Xu C; Guo X; Yu J; Chen T; Facchinetti F; Bohnenberger H; Leong TL; Xie Y; Mao X; Zhao J
Transl Lung Cancer Res; 2021 Oct; 10(10):3995-4011. PubMed ID: 34858787
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
[TBL] [Abstract][Full Text] [Related]
5. USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation.
Li Y; Zhou J
Cancer Manag Res; 2021; 13():3913-3924. PubMed ID: 34012297
[TBL] [Abstract][Full Text] [Related]
6. Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.
Jin WL; Mao XY; Qiu GZ
Med Res Rev; 2017 May; 37(3):627-661. PubMed ID: 27775833
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2.
Du Y; Lin J; Zhang R; Yang W; Quan H; Zang L; Han Y; Li B; Sun H; Wu J
Aging (Albany NY); 2019 Nov; 11(21):9778-9793. PubMed ID: 31727867
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of USP5 contributes to tumorigenesis in non-small cell lung cancer via the stabilization of β-catenin protein.
Ma X; Qi W; Pan H; Yang F; Deng J
Am J Cancer Res; 2018; 8(11):2284-2295. PubMed ID: 30555744
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor.
Xu X; Huang A; Cui X; Han K; Hou X; Wang Q; Cui L; Yang Y
Theranostics; 2019; 9(14):4208-4220. PubMed ID: 31281542
[TBL] [Abstract][Full Text] [Related]
10. A pan-cancer analysis of the role of USP5 in human cancers.
Yan B; Guo J; Deng S; Chen D; Huang M
Sci Rep; 2023 Jun; 13(1):8972. PubMed ID: 37268697
[TBL] [Abstract][Full Text] [Related]
11. Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma.
Liu Y; Wang WM; Lu YF; Feng L; Li L; Pan MZ; Sun Y; Suen CW; Guo W; Pang JX; Zhang JF; Fu WM
Oncotarget; 2017 Aug; 8(31):50655-50664. PubMed ID: 28881591
[TBL] [Abstract][Full Text] [Related]
12. The deubiquitinase Leon/USP5 interacts with Atg1/ULK1 and antagonizes autophagy.
Pai YL; Lin YJ; Peng WH; Huang LT; Chou HY; Wang CH; Chien CT; Chen GC
Cell Death Dis; 2023 Aug; 14(8):540. PubMed ID: 37607937
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
[TBL] [Abstract][Full Text] [Related]
14. USP5 promotes tumorigenesis by activating Hedgehog/Gli1 signaling pathway in osteosarcoma.
Wu Q; Liu R; Yang Y; Peng J; Huang J; Li Z; Huang K; Zhu X
Am J Cancer Res; 2024; 14(3):1204-1216. PubMed ID: 38590401
[TBL] [Abstract][Full Text] [Related]
15. Targeting Ubiquitin-specific Protease 5 Overcomes Chemoresistance via Negatively Regulating p53 in Gastric Cancer.
Song J; Liu L; Wang F; Bao D
Curr Mol Med; 2024 Feb; ():. PubMed ID: 38347776
[TBL] [Abstract][Full Text] [Related]
16. USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α.
Huang W; Liu X; Zhang Y; Deng M; Li G; Chen G; Yu L; Jin L; Liu T; Wang Y; Chen Y
J Cell Physiol; 2022 Apr; 237(4):2211-2219. PubMed ID: 35102545
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells.
Potu H; Kandarpa M; Peterson LF; Donato NJ; Talpaz M
Oncotarget; 2019 Oct; 10(56):5745-5754. PubMed ID: 31645897
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
[TBL] [Abstract][Full Text] [Related]
19. USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila.
Ristic G; Tsou WL; Guzi E; Kanack AJ; Scaglione KM; Todi SV
J Biol Chem; 2016 Apr; 291(17):9161-72. PubMed ID: 26917723
[TBL] [Abstract][Full Text] [Related]
20. miR-125a suppresses malignancy of multiple myeloma by reducing the deubiquitinase USP5.
Wu L; Zhang C; Chu M; Fan Y; Wei L; Li Z; Yao Y; Zhuang W
J Cell Biochem; 2020 Jan; 121(1):642-650. PubMed ID: 31452281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
